Diagnostic Impact of Dual-Time PET/CT with <sup>68</sup>Gallium-PSMA in Prostate Cancer and <sup>68</sup>Gallium-DOTATOC in Neuroendocrine Tumors

Diagnostic Impact of Dual-Time PET/CT with <sup>68</sup>Gallium-PSMA in Prostate Cancer and <sup>68</sup>Gallium-DOTATOC in Neuroendocrine Tumors

Background: The timing of imaging for <sup>68</sup>gallium (<sup>68</sup>Ga)-PSMA and <sup>68</sup>Ga-DOTATOC are stated to be around 60 min post-injection (p.i.). In some lesions, late imaging (3–4 h p.i.) showed advantages. The aim of our evaluation was to demon...

Full description

Bibliographic Details
Main Authors: Damiano Librizzi, Friederike Eilsberger, Stefan Ottenthaler, Ali Ebrahimifard, Markus Luster, Behrooz H. Yousefi
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Biomedicines
Subjects:
<sup>68</sup>gallium
PET/CT
dual-time
PSMA
DOTATOC
prostate cancer
Online Access:https://www.mdpi.com/2227-9059/11/4/1052

Similar Items

Similar Items